This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Jim Cramer's 'Mad Money' Recap: Profits Still Matter

Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.

NEW YORK (TheStreet) -- Investors who are focusing only on Vladimir Putin are missing the point, Jim Cramer said on "Mad Money" Tuesday. When it comes to investing, profits matter. They always have and they always will.

That might seem like a foreign notion to many investors, however -- the Wall Street hedge fund machine isn't bound by logic. Cramer explained that big fund managers need to make money whether the market is going up or down, so they're constantly on the lookout for negative news as much as positive news.

A typical day for a hedge fund manager would start out in Russia, said Cramer. But without any bad news from Ukraine, the managers probably quickly turned to China. Unfortunately, there wasn't any bad news from China either, sending managers to scour the rest of the usual subjects, including Europe, Japan and the emerging markets.

But with a bad news shortage in most of the world today, that left managers to turn back to the good old U.S., Cramer continued. Housing starts and permits were right in line and the consumer price index showed only a modest 0.1%. Then, and only then, were fund managers convinced that today was indeed a good day to buy stocks instead of shorting everything.

And that is how the markets were able to rally, Cramer concluded.

Executive Decision: Jim Foster

For his "Executive Decision" segment, Cramer spoke with Jim Foster, chairman, president and CEO of Charles River Labs (CRL), a stock that's gained 49% since Cramer last checked in back in May.

Foster said biotechs and big pharma companies continue to reduce their clinical testing infrastructure and Charles River continues to be there to pick up the slack, making acquisitions to become more responsive to clients' needs.

Foster explained that thus far Charles River has focused on later-stage testing with animals, but his company is now moving earlier in the drug discovery process to help companies make go, no-go decisions faster and eliminate wasteful spending.

Foster also said that just as technology is rapidly moving forward for humans, the world of animal testing is also advancing, allowing animals like mice to become "humanized," or able to respond to drugs more like humans would.

1 of 3

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,987.51 -61.49 -0.36%
S&P 500 1,985.54 -11.91 -0.60%
NASDAQ 4,567.5980 -24.2080 -0.53%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs